Concurrent Chemoradiotherapy for Patients With Postoperative Recurrence of Surgically Resected Non–Small-Cell Lung Cancer-Reference-Cited by-同舟云学术

Concurrent Chemoradiotherapy for Patients With Postoperative Recurrence of Surgically Resected Non–Small-Cell Lung Cancer

Published:2015-01 Issue:1 Volume:16 Page:51-56
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Takenaka Tomoyoshi,Takenoyama Mitsuhiro,Toyozawa Ryo,Inamasu Eiko,Yoshida Tsukihisa,Toyokawa Gouji,Shiraishi Yoshimasa,Hirai Fumihiko,Yamaguchi Masafumi,Seto Takashi,Ichinose Yukito

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference25 articles.

1. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008;Ferlay;Int J Cancer,2010

2. Post-recurrence survival in completely resected stage I non-small cell lung cancer with local recurrence;Hung;Thorax,2009

3. Prognostic factors of postrecurrence survival in completely resected stage I non-small cell lung cancer with distant metastasis;Hung;Thorax,2010

4. Predicting postrecurrence survival among completely resected nonsmall-cell lung cancer patients;Williams;Ann Thorac Surg,2006

5. Results of long-term follow-up of patients with completely resected non-small cell lung cancer;Endo;Ann Thorac Surg,2012

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognosis of non‐small cell lung cancer with postoperative regional lymph node recurrence;Thoracic Cancer;2024-02-27

2. Prognosis of patients with recurrent nonsmall cell lung cancer who received the best supportive care alone;Current Problems in Surgery;2024-01

3. Is radical local therapy effective in postoperative recurrent EGFR‐mutated non‐small cell lung cancer?;Thoracic Cancer;2023-05-04

4. The value of completion residual lung resection in ipsilateral recurrent non-small cell lung cancer;Frontiers in Surgery;2022-11-09

5. Chemo-radiotherapy plus durvalumab for loco-regional relapse of resected NSCLC;Radiation Oncology;2022-07-16